세계의 심폐기 시장 성장, 규모, 동향 분석 : 구성요소, 용도, 최종사용자별 - 지역별 전망, 경쟁 전략, 부문 예측(-2034년)

Heart lung Machine Market Introduction and Overview

According to SPER Market Research, 'Global Heart-lung Machine Market Size - By Component, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Heart-lung Machine Market is predicted to reach 4.99 billion by 2034 with a CAGR of 7.15%.

The heart-lung machine, also referred to as the cardiopulmonary bypass (CPB) machine, is a tool used to temporarily replace the heart and lungs during open heart surgery. By removing blood from the heart and lungs, oxygenating it, and then reintroducing it into the body, it enables surgeons to do surgery on a still heart. A pump, an oxygenator, and other monitoring and control systems make up the machine. As the pump circulates blood throughout the body, the oxygenator removes carbon dioxide and adds oxygen to the blood.

Restraints: Despite the favorable factors propelling the global market for heart-lung machines, certain barriers impede its expansion. For example, the high expense of heart-lung machines and their upkeep prevents them from being widely used, especially in developing nations. The use of these devices in smaller healthcare facilities with fewer resources may be restricted due to the complexity of their operation and maintenance, which calls for specialized training.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Component, By Application, By End-User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Braile BiomA(C)dica, ELITE LIFECARE, Getinge, Hemovent GmbH, LivaNova, Inc, Medtronic, MERA (Senko Medical Instrument Mfg. Co, Ltd), NIPRO, Technowood International Pte Ltd.

Global Heart-lung Machine Market Segmentation:

By Component: Based on the Component, Global Heart-lung Machine Market is segmented as; Oxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Blood Reservoir, Others.

By Application: Based on the Application, Global Heart-lung Machine Market is segmented as; Coronary Artery Bypass Grafting (CABG), Heart Valve Surgeries, Heart Transplant, Lung Transplant, Others.

By End-User: Based on the End-User, Global Heart-lung Machine Market is segmented as; Hospitals, Cardiac Centers, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1.Introduction

• 1.1.Scope of the report
• 1.2.Market segment analysis

2.Research Methodology

• 2.1.Research data source
  • 2.1.1.Secondary Data
  • 2.1.2.Primary Data
  • 2.1.3.SPERs internal database
  • 2.1.4.Premium insight from KOLs
• 2.2.Market size estimation
  • 2.2.1.Top-down and Bottom-up approach
• 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

• 4.1.Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1.Drivers
  • 4.1.2.Restraints
  • 4.1.3.Opportunities
  • 4.1.4.Challenges

5.Market variable and outlook

• 5.1.SWOT Analysis
  • 5.1.1.Strengths
  • 5.1.2.Weaknesses
  • 5.1.3.Opportunities
  • 5.1.4.Threats
• 5.2.PESTEL Analysis
  • 5.2.1.Political Landscape
  • 5.2.2.Economic Landscape
  • 5.2.3.Social Landscape
  • 5.2.4.Technological Landscape
  • 5.2.5.Environmental Landscape
  • 5.2.6.Legal Landscape
• 5.3.PORTERs Five Forces
  • 5.3.1.Bargaining power of suppliers
  • 5.3.2.Bargaining power of buyers
  • 5.3.3.Threat of Substitute
  • 5.3.4.Threat of new entrant
  • 5.3.5.Competitive rivalry
• 5.4.Heat Map Analysis

6.Competitive Landscape

• 6.1.Global Heart-lung Machine Market Manufacturing Base Distribution, Sales Area, Interface Type
• 6.2.Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Heart-lung Machine Market

7.Global Heart-lung Machine Market, By Component 2021-2034 (USD Million)

• 7.1.Oxygenators
• 7.2.Pumps
• 7.3.Cannula
• 7.4.Monitoring Systems
• 7.5.Heat Exchanger Units
• 7.6.Blood Reservoir
• 7.7.Others

8.Global Heart-lung Machine Market, By Application 2021-2034 (USD Million)

• 8.1.Coronary Artery Bypass Grafting (CABG)
• 8.2.Heart Valve Surgeries
• 8.3.Heart Transplant
• 8.4.Lung Transplant
• 8.5.Others

9.Global Heart-lung Machine Market, By End-User 2021-2034 (USD Million)

• 9.1.Hospitals
• 9.2.Cardiac Centers
• 9.3.Others

10.Global Heart-lung Machine Market, 2021-2034 (USD Million)

• 10.1.Global Heart-lung Machine Market Size and Market Share

11.Global Heart-lung Machine Market, By Region, 2021-2034 (USD Million)

• 11.1.Asia-Pacific
  • 11.1.1.Australia
  • 11.1.2.China
  • 11.1.3.India
  • 11.1.4.Japan
  • 11.1.5.South Korea
  • 11.1.6.Rest of Asia-Pacific
• 11.2.Europe
  • 11.2.1.France
  • 11.2.2.Germany
  • 11.2.3.Italy
  • 11.2.4.Spain
  • 11.2.5.United Kingdom
  • 11.2.6.Rest of Europe
• 11.3.Middle East and Africa
  • 11.3.1.Kingdom of Saudi Arabia
  • 11.3.2.United Arab Emirates
  • 11.3.3.Qatar
  • 11.3.4.South Africa
  • 11.3.5.Egypt
  • 11.3.6.Morocco
  • 11.3.7.Nigeria
  • 11.3.8.Rest of Middle-East and Africa
• 11.4.North America
  • 11.4.1.Canada
  • 11.4.2.Mexico
  • 11.4.3.United States
• 11.5.Latin America
  • 11.5.1.Argentina
  • 11.5.2.Brazil
  • 11.5.3.Rest of Latin America

12.Company Profile

• 12.1.Braile BiomA(C)dica
  • 12.1.1.Company details
  • 12.1.2.Financial outlook
  • 12.1.3.Interface summary
  • 12.1.4.Recent developments
• 12.2.ELITE LIFECARE
  • 12.2.1.Company details
  • 12.2.2.Financial outlook
  • 12.2.3.Interface summary
  • 12.2.4.Recent developments
• 12.3.Getinge
  • 12.3.1.Company details
  • 12.3.2.Financial outlook
  • 12.3.3.Interface summary
  • 12.3.4.Recent developments
• 12.4.Hemovent GmbH
  • 12.4.1.Company details
  • 12.4.2.Financial outlook
  • 12.4.3.Interface summary
  • 12.4.4.Recent developments
• 12.5.LivaNova, Inc
  • 12.5.1.Company details
  • 12.5.2.Financial outlook
  • 12.5.3.Interface summary
  • 12.5.4.Recent developments
• 12.6.Medtronic
  • 12.6.1.Company details
  • 12.6.2.Financial outlook
  • 12.6.3.Interface summary
  • 12.6.4.Recent developments
• 12.7.MERA (Senko Medical Instrument Mfg. Co., Ltd)
  • 12.7.1.Company details
  • 12.7.2.Financial outlook
  • 12.7.3.Interface summary
  • 12.7.4.Recent developments
• 12.8.NIPRO
  • 12.8.1.Company details
  • 12.8.2.Financial outlook
  • 12.8.3.Interface summary
  • 12.8.4.Recent developments
• 12.9.Technowood International Pte. Ltd
  • 12.9.1.Company details
  • 12.9.2.Financial outlook
  • 12.9.3.Interface summary
  • 12.9.4.Recent developments
  • 12.9.5.Others

13.Conclusion

14.List of Abbreviations

15.Reference Links